
Funding Opportunities
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional) RFA-CA-21-019 |
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) RFA-CA-21-013 |
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) RFA-CA-21-014 |
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) RFA-CA-21-015 |
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) RFA-CA-21-016 |
Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional) RFA-CA-21-017 |
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) RFA-CA-21-003 |
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) RFA-CA-21-005 |
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) RFA-CA-21-006 |
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) RFA-CA-21-004 |
Collaborative Approaches to Engineer Biology for Cancer Applications (U01 Clinical Trial Not Allowed) RFA-CA-20-054 |
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) PAR-20-287 |
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) PAR-20-288 |
Research Answers to NCI’s Provocative Questions (R01 Clinical Trial Optional) RFA-CA-20-004 |
Research Answers to NCI’s Provocative Questions (R21 Clinical Trial Optional) RFA-CA-20-005 |
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) RFA-CA-20-017 |
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) RFA-CA-20-018 |
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) RFA-CA-20-019 |
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) RFA-CA-20-020 |
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed) RFA-CA-19-022 |